#USA #Plantation #BioMatrix Infusion #LUX Infusion #Infusion Services

A Landmark Acquisition in Infusion Healthcare

On October 17, 2025, BioMatrix Infusion Pharmacy announced the successful acquisition of LUX Infusion, a renowned ambulatory infusion center in Alaska. This strategic move marks a significant expansion for BioMatrix, enhancing its nationwide footprint for ambulatory infusion services. With LUX Infusion operating three state-of-the-art centers across Alaska, the acquisition is set to revolutionize the landscape of infusion therapy provision in the region.

Shared Commitment to Excellence

Ted Kramm, CEO of BioMatrix Infusion Pharmacy, emphasized that this acquisition is driven by a mutual commitment to enhancing access, quality, and innovation in ambulatory infusion care. "Together, we are better positioned to transform infusion care delivery and ensure that patients nationwide receive the highest standard of treatment," Kramm stated.

LUX Infusion, co-founded by Lisa Bruce, has established a reputation for providing exceptional patient care, operating in a model designed for comfort and cost-effectiveness. Bruce expressed enthusiasm for the new partnership, noting, "Partnering with BioMatrix strengthens our commitment and allows us to expand this model nationwide."

Strategic Advantages of the Acquisition

This acquisition presents several strategic benefits for BioMatrix, reinforcing its market position in several ways:

1. Expanded Reach: The inclusion of three LUX infusion centers in Alaska enhances BioMatrix's ability to cater to key growth markets, addressing the rising demand for infusion services across the nation.

2. Enhanced Clinical Capabilities: By integrating LUX's skilled care teams, BioMatrix can enhance its operational framework, thereby improving patient outcomes and experience.

3. Accelerated Growth and Innovation: Combining resources enables BioMatrix to scale new infusion sites more efficiently while expanding therapy options available to patients.

4. Strengthened Home Infusion Services: The acquisition extends BioMatrix's home infusion nursing capabilities into the Pacific Northwest, facilitating increased access for patients who prefer treatments at home.

5. Greater Value Creation: Expanding access and improving patient outcomes will deepen partnerships with providers and payers, ensuring a more integrated approach to patient care.

Recently, LUX Infusion achieved NICA accreditation and was recognized as an AICE-Ambulatory Infusion Center of Excellence, underlining their commitment to delivering safe and high-quality infusion care.

BioMatrix’s Vision Moving Forward

With this acquisition, BioMatrix is positioning itself as one of the most comprehensive infusion pharmacy providers in the nation. The integration marks a pivotal step in furthering their commitment to deliver best-in-class care for complex and chronic conditions.

BioMatrix Infusion Pharmacy prides itself on being a trusted, independent specialty infusion pharmacy with decades of experience in the healthcare sector. They focus on providing personalized care, assisting patients through their healthcare journeys while ensuring continuity and optimal clinical outcomes.

About BioMatrix Infusion Pharmacy

Established with a mission to revolutionize infusion services, BioMatrix Infusion Pharmacy has built its operations around compassion and excellence in healthcare. For more information, you can visit www.biomatrixsprx.com.

About LUX Infusion

LUX Infusion has emerged as Alaska's leading independent ambulatory infusion provider, known for its safe, convenient, and cost-efficient care for patients dealing with acute and chronic conditions. To find out more about LUX, visit www.luxinfusion.com.